Research

Clinical and Translational Medicine

Clinical Outcomes of Obesity Management

  • Neuroprotective Effects of GLP-1 Receptor Agonists in Neurodegenerative Disorders: A Large-Scale Propensity-Matched Cohort Study. International Immunopharmacology, 2024

  • Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Complex Impact on Calcium Homeostasis in Real-World Patients. Journal of Clinical Medicine, 2024

  • Differential effects of GLP-1 receptor agonists on cancer risk in obesity: A nationwide analysis of 1.1 million patients. Cancers, 2025

  • Increased Risk of Hypoglycemia Following Roux-en-Y Gastric Bypass Surgery in Non-Diabetic Obese Patients: A Propensity Score-Matched Analysis. Obesity Surgery, 2024

Surgical Outcomes and Treatment Responses

  • Comparative Efficacy, Safety, and Oncological Outcomes of Percutaneous Thermal and Chemical Ablation Modalities for Recurrent Metastatic Cervical Lymphadenopathy from Thyroid Cancer. Surgical Oncology, 2024

  • Treatment outcomes in patients with papillary thyroid cancer undergoing Radiofrequency ablation of metastatic lymph nodes. Gland Surgery, 2024

  • Survival outcomes of medullary thyroid cancer with and without amyloid deposition. Endocrine Practice, 2024

  • Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact. Cancers, 2023

Diagnostic Imaging and Detection

  • A combination of Computed Tomography Scan and Ultrasound Provides Optimal Detection of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinomas: A Systematic Review and Meta-Analysis. Head & Neck, 2023

Special Populations and Treatment Effects

  • Higher incidence of dermatological immune-related adverse events in cancer patients treated with immune checkpoint inhibitors vs. other treatments: A TriNetX Research Network study. Archives of Dermatological Research, 2025

  • Timing Matters: The Impact of Age at CFTR Modulator Therapy Initiation in Cystic Fibrosis. Children, 2025

MicroRNA and Molecular Signatures

  • Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer. Biomedicine, 2023

  • Chromatin-accessible miRNA regulons driving thyroid tumorigenesis and progression. Journal of the American College of Surgeons, 2023

  • Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo. Scientific Reports, 2022

Genomic Integration and Biomarker Discovery

  • GEMIN4 Variants: Risk Profiling, Bioinformatics and Dynamic Simulations Uncover Bladder Carcinoma Susceptibility. Archives of Medical Research, 2024

  • The Prevalence and Prognostic Implications of BRAF K601E Mutations in Thyroid Cancer. Head & Neck, 2024

Non-coding RNA and Disease Mechanisms

  • Impacts of DROSHA (rs10719) and DICER (rs3742330) Variants on Breast Cancer Risk and Their Distribution in Blood and Tissue Samples. Current Issues in Molecular Biology, 2024

  • Long non-coding RNA MALAT1 and microRNA-499a expression profiles in diabetic ESRD patients undergoing dialysis. Archives of Physiology and Biochemistry, 2024

  • A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer. Cancers, 2022.

Molecular Progression Markers

  • MicroRNA-based risk score for predicting tumor progression following radioactive iodine ablation in well-differentiated thyroid cancer. Cancers, 2023.

  • Genetics variants and breast carcinoma susceptibility: Unveiling the Role of MTHFR and TP53. Gene Reports, 2024.

  • MicroRNA-155 and disease-related immunohistochemical parameters in cutaneous melanoma. Diagnostics, 2023.

  • Prognostic value of BRAF, programmed cell death 1 (PD1), and PD ligand 1 (PDL1) protein expression in colorectal adenocarcinoma. Diagnostics (Basel). 2023

Precision Medicine and Multi-omics Integration

Language and Culture

  • Lost in Translation: Exploring the Exposome Link between Linguistic Isolation and Cancer Risk in the United States
    Cancer Causes & Control, 2024

  • Elevated Cardiovascular and Hematological Risks in Jehovah's Witnesses with Menstrual Irregularities: A Large-Scale Propensity-Matched Cohort Study. Under review.

Socioeconomic Disparities

  • Income Disparities Have a Significant Impact on Thyroid Cancer Recurrence and Survival. Journal of Cancer Policy, 2024

  • Social Exposome and the Tip of Iceberg in Diagnosing Thyroid Cancer in Disproportionately Affected Communities: A US population-based Multi-Ethnic Study
    Journal of Cancer Policy, 2024

  • Housing instability and musculoskeletal health: a retrospective cohort study revealing gender disparities and elevated risks among unhoused populations. Under review.

  • The Glaucoma Paradox: Socioeconomic Status and the Unexpected Dynamics of Disease Progression. Under review.

Environmental Health and Disease Risk

  • Type 2 Diabetes and Thyroid Cancer: Synergized Risk with Rising Air Pollution. World Journal of Diabetes, 2024

  • Elucidating the Link Between Thyroid Cancer and Mercury Exposure. Environmental Science and Pollution Research, 2024.

  • Gender and Race Demographics of Fellowships After General Surgery Training in the United States: A Five-Year Analysis in Applicant and Resident Trends. The American Journal of Surgery, 2023.

  • Ultraviolet Light Exposure Decreases Thyroid Cancer Risk: A National Perspective. Biomedicines, 2022.

Healthcare Access and Outcomes

  • Navigating Choices: Determinants and Outcomes of Surgery Refusal in Thyroid Cancer Patients Using SEER Data. Cancers, 2024.

  • How does Insurance Status Correlate with Trauma Mechanisms and Outcomes? A Retrospective Study at a Level 1 Trauma Center. The American Surgeon, 2022.

  • The racial and sexual disparity in emergency department visits for sport-related spine fracture injuries: A NEISS database study. Injury, 2024.

Population Health and Equity